Is This Blue-Chip Dividend Stock a Buy?
Picking the best stocks in industries with promising growth prospects is the not-so-secret strategy to build significant wealth over the long term as an investor.
Few industries arguably have as bright of a future as health insurance. Growing medical care costs and chronic medical conditions becoming more prevalent bode well for the industry. This is why the global health insurance industry is expected to compound at a 5.5% annual rate from $2.1 trillion in 2021 to $3 trillion by 2028.
And Humana's (NYSE: HUM) $55 billion market capitalization makes it the fifth-biggest publicly traded health insurer on the planet. But is the stock currently a buy? Let's take a look at Humana's fundamentals and valuation to decide.
Source Fool.com
